Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CB1151 is a 20-epi analogue of 1,25 dihydroxyvitamin D3 with anti-tumor effects. It inhibits MCF-7 cell growth (IC50: 0.82 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 995.00 |
Description | CB1151 is a 20-epi analogue of 1,25 dihydroxyvitamin D3 with anti-tumor effects. It inhibits MCF-7 cell growth (IC50: 0.82 nM). |
In vitro | CB1151 (0-100 nM; 5 days) inhibits MCF-7 cells growth, this cell proliferation is accessed by [3H]-thymidine incorporation (IC50: 0.82 nM). CB1151 (0-100 nM; 40 hours) exhibits activation of the IP9-type VD response element (EC50: 1.2 nM), the activation of IP9-type VD response elements shows a good correlation with inhibition of proliferation than the activation of DR3-type elements (EC50: 3.2nM) in MCF-7 cells transfected with the CAT reporter [1]. CB1151 shows a functional dissociation constant (Kdf) value of 3.6 nM. The ligand concentration that provides 50% of the protease-resistant VDR fragment is defined by Kdf [2]. |
Molecular Weight | 446.672 |
Formula | C28H46O4 |
CAS No. | 182369-28-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CB1151 182369-28-4 Others CB 1151 CB-1151 inhibitor inhibit